Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

EXtended Therapy in Genotype 3 Infected Patients Who do Not AChieve a Treatment Response at Week 4 (RVR) But do Achieve a Complete Early Virologic Response (cEVR)

NCT01095445 is registered in ClinicalTrials.gov with University Health Network, Toronto as lead sponsor.

NCT NCT01095445
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01095445 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
EXtended Therapy in Genotype 3 Infected Patients Who do Not AChieve a Treatment Response at Week 4 (RVR) But do Achieve a Complete Early Virologic Response (cEVR)
Lead sponsor
University Health Network, Toronto
Phase
Phase 3
Overall status
Terminated
Start date
February 28, 2010
Completion date
June 30, 2011
Enrollment
2 (actual)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

chronic hepatitis c